Melanoma
Research from University of Michigan in the area of melanoma published
Published in Vaccine Weekly, September 24th, 2008
According to recent research published in the Journal of Immunotherapy, "Twenty-four subjects with metastatic melanoma were treated on a randomized Phase Ib trial evaluating an autologous tumor lysate-pulsed dendritic cell (DC) vaccine with or without interleukin (IL)-2. The vaccine consisted of autologous DCs obtained from peripheral blood mononuclear cells (PBMCs) cultured in granulocyte macrophage-colony stimulating factor and IL-4 then pulsed with autologous tumor cell lysate and keyhole limpet hemocyanin (KLH)."
"The primary end points of the trial were safety and immune response to vaccine. Subjects were randomized to vaccine administered every other week...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-09-24)
More Articles from Vaccine Weekly
- Gladstone Institutes
Gladstone scientists identify genetic link that may neutralize HIV - NIH/National Institute of Allergy and Infectious Diseases
Study reveals link between Apobec3 gene and neutralizing antibody response to retrovirus - Anthrax
New findings from National Institutes of Health in the area of anthrax published - Immunization
Data on immunization discussed by D. Holland and colleagues - Immunization
New immunization study findings recently were published by M. Jit and co-researchers - Immunization
Reports by B.R. Sellman and co-researchers describe recent advances in immunization - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
